Socioeconomic differences in the uptake of home dialysis

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 5, 2014, Pages 929-935

  Grace, Blair S ^a,b   Clayton, Philip A ^a,c,d   Gray, Nicholas A ^a,e,f   McDonald, Stephen P ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e NAMBOUR GENERAL HOSPITAL   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BODY MASS; COMORBIDITY; COST; FEMALE; FOLLOW UP; FUNDING; HEALTH CENTER; HEMODIALYSIS; HOME DIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT REFERRAL; PERITONEAL DIALYSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; RURAL AREA; SMOKING; SOCIOECONOMICS; INSURANCE; OUTPATIENT DEPARTMENT; POVERTY; PRIVATE HOSPITAL; REGISTER; RENAL INSUFFICIENCY, CHRONIC; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; AMBULATORY CARE FACILITIES; AUSTRALIA; FEMALE; HEMODIALYSIS, HOME; HOSPITALS, PRIVATE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; POVERTY AREAS; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RURAL POPULATION; SOCIOECONOMIC FACTORS; UNIVERSAL COVERAGE;

EID: 84922479774     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08770813     Document Type: Article

References (41)

1. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C: Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis 40: 611–622, 2002.
2. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR: Relationship between dialysis modality and mortality. J Am Soc Nephrol 20: 155–163, 2009.
3. Chiu YW, Jiwakanon S, Lukowsky L, Duong U, Kalantar-Zadeh K, Mehrotra R: An update on the comparisons of mortality outcomes of hemodialysis and peritoneal dialysis patients. Semin Nephrol 31: 152–158, 2011.
4. Kutner NG, Zhang R, Barnhart H, Collins AJ: Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant 20: 2159–2167, 2005.
5. Mowatt G, Vale L, MacLeod A: Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care 20: 258–268, 2004.
6. Stokes JB: Nocturnal hemodialysis: Analysis following the Frequent Hemodialysis Network trial. Semin Dial 24: 614–620, 2011.
7. Stack AG: Determinants of modality selection among incident US dialysis patients: Results from a national study. J Am Soc Nephrol 13: 1279–1287, 2002.
8. Gadegbeku C, Freeman M, Agodoa L: Racial disparities in renal replacement therapy. J Natl Med Assoc 94[Suppl]: 45S–54S, 2002.
9. Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW; Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group: The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 43: 891–899, 2004.
10. Huang HC, Wang JY, Chang CC, Chiu PF, Chiang MC, Yang Y: Nonclinical factors associated with treatment with peritoneal dialysis in ESRD patients in Taiwan. Perit Dial Int 30: 638–643, 2010.
11. Prakash S, Perzynski AT, Austin PC, Wu CF, Lawless ME, Paterson JM, Quinn RR, Sehgal AR, Oliver MJ: Neighborhood socioeco-nomic status and barriers to peritoneal dialysis: A mixed methods study. Clin J Am Soc Nephrol 8: 1741–1749, 2013.
12. Walker DR, Inglese GW, Sloand JA, Just PM: Dialysis facility and patient characteristics associated with utilization of home dialysis. Clin J Am Soc Nephrol 5: 1649–1654, 2010.
13. US Renal Data System: International comparisons. In: USRDS: 2010 Annual Report, Bethesda,MD, National Insitutes of Health, National Insitute of Diabetes and Digestive and Kidney Diseases, 2010, pp 385–397.
14. Preston-Thomas A, Cass A, O’Rourke P: Trends in the incidence of treated end-stage kidney disease among Indigenous Australians and access to treatment. Aust N Z J Public Health 31: 419–421, 2007.
15. Australian Bureau of Statistics: Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia. ABS Catalogue 2033.0.55, Canberra, Australia, Australian Bureau of Statistics, 2008.
16. Grace BS, Clayton P, Cass A, McDonald SP: Socio-economic status and incidence of renal replacement therapy: A registry study of Australian patients. Nephrol Dial Transplant 27: 4173–4180, 2012.
17. Grace BS, Clayton PA, Cass A, McDonald SP: Transplantation rates for living- but not deceased-donor kidneys vary with so-cioeconomic status in Australia. Kidney Int 83: 138–145, 2013.
18. Australian Bureauof Statistics: Australian Standard Geographical Classification. ABS Catalogue No. 1216.0, Canberra, Australia, Australian Bureau of Statistics, 2010.
19. Kidney Health Australia: Dialysis Unit Guide, Adelaide, SA, Australia, Kidney Health Australia, 2012.
20. Maller RA, Zhou X: Survival Analysis with Long-Term Survivors, New York, Wiley, 2001.
21. Couchoud C, Bayat S, Villar E, Jacquelinet C, Ecochard R; REIN registry: A new approach for measuring gender disparity in access to renal transplantation waiting lists. Transplantation 94: 513–519, 2012.
22. Cleves M, Gurierrez RG, Gould W, Marchenko YV: An Introduction to Survival Analysis Using Stata, College Station, TX, Stata Press, 2010.
23. Baker SG: Causal inference, probability theory, and graphical insights [published online ahead of print May 10, 2013]. Stat Med 32: 4310–4330, 2013.
24. Fine J, Gray R: A proportional hazards model for the sub-distribution of a competing risk. J Am Stat Assoc 94: 496–509, 1999.
25. Gray NA, Dent H, McDonald SP: Dialysis in public and private hospitals in Queensland. Intern Med J 42: 887–893, 2012.
26. Lameire N, Van Biesen W: Epidemiology of peritoneal dialysis: A story of believers and nonbelievers. Nat Rev Nephrol 6: 75–82, 2010.
27. Cleemput I, De Laet C: Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities. Health Policy 110: 172–179, 2013.
28. Vanholder R, Davenport A, Hannedouche T, Kooman J, Kribben A, Lameire N, Lonnemann G, Magner P, Mendelssohn D, Saggi SJ, Shaffer RN, Moe SM, Van Biesen W, Vander Sande F, Mehrotra R; Dialysis Advisory Group of American Society of Nephrology: Reimbursement of dialysis: A comparison of seven countries. J Am Soc Nephrol 23: 1291–1298, 2012.
29. Gray NA, Grace BS, McDonald SP: Peritoneal dialysis in rural Australia. BMC Nephrol 14: 278, 2013.
30. Barker-Cummings C, McClellan W, Soucie JM, Krisher J: Ethnic differences in the use of peritoneal dialysis as initial treatment for end-stage renal disease. JAMA 274: 1858–1862, 1995.
31. Morton RL, Howard K, Webster AC, Snelling P: Patient INformation about Options for Treatment (PINOT): Prospective national study of information given to incident CKD Stage 5 patients. Nephrol Dial Transplant 26: 1266–1274, 2011.
32. Manns BJ, Taub K, Vanderstraeten C, Jones H, Mills C, Visser M, McLaughlin K: The impact of education on chronic kidney disease patients’ plans to initiate dialysis with self-care dialysis: A randomized trial. Kidney Int 68: 1777–1783, 2005.
33. Winkelmayer WC, Glynn RJ, Levin R, Owen W Jr., Avorn J: Late referral and modality choice in end-stage renal disease. Kidney Int 60: 1547–1554, 2001.
34. Zhang AH, Bargman JM, Lok CE, Porter E, Mendez M, Oreopoulos DG, Chan CT: Dialysis modality choices among chronic kidney disease patients: Identifying the gaps to support patients on home-based therapies. Int Urol Nephrol 42: 759– 764, 2010.
35. Ludlow MJ, George CRP, Hawley CM, Mathew TH, Agar JWM, Kerr PG, Lauder LA: How Australian nephrologists view home dialysis: Results of a national survey. Nephrology (Carlton) 16: 446–452, 2011.
36. Kidney Health Australia: Financial Support for Home Dialysis Patients in Australia, Adelaide, SA, Australia, KHA, 2012.
37. Nitsch D, Steenkamp R, Tomson CRV, Roderick P, Ansell D, MacGregor MS: Outcomes in patientson homehaemodialysis in England and Wales, 1997–2005: A comparative cohort analysis. Nephrol Dial Transplant 26: 1670–1677, 2011.
38. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemo-dialysis prescription of patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176–1181, 1981.
39. Link BG, Phelan J: Social conditions as fundamental causes of disease. J Health Soc Behav Spec No: 80–94, 1995.
40. Bentley R, Kavanagh AM, Subramanian SV, Turrell G: Area disadvantage, individual socio-economic position, and premature cancer mortality in Australia 1998 to 2000: A multilevel analysis. Cancer Causes Control 19: 183–193, 2008.
41. Gray NA, Mahadevan K, Campbell VK, Noble EP, Anstey CM: Data quality of the Australia and New Zealand Dialysis and Transplant Registry: A pilot audit. Nephrology (Carlton) 18: 665–670, 2013.